Literature DB >> 12837821

The prostate cancer conundrum.

Peter C Albertsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837821     DOI: 10.1093/jnci/95.13.930

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up.

Authors:  Grace Lu-Yao; Peter C Albertsen; Janet L Stanford; Therese A Stukel; Elizabeth Walker-Corkery; Michael J Barry
Journal:  J Gen Intern Med       Date:  2008-09-16       Impact factor: 5.128

2.  The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.

Authors:  Michael J Barry; Michael A Delorenzo; Elizabeth S Walker-Corkery; F Lee Lucas; David C Wennberg
Journal:  BJU Int       Date:  2006-07-28       Impact factor: 5.588

3.  The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.

Authors:  Ruth Etzioni; Roman Gulati; Alex Tsodikov; Elisabeth M Wever; David F Penson; Eveline A M Heijnsdijk; Jeffrey Katcher; Gerrit Draisma; Eric J Feuer; Harry J de Koning; Angela B Mariotto
Journal:  Cancer       Date:  2012-05-17       Impact factor: 6.860

4.  Insights from the PLCO trial about prostate cancer screening.

Authors:  Roman Gulati; Peter C Albertsen
Journal:  Cancer       Date:  2016-12-01       Impact factor: 6.860

5.  Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States.

Authors:  Megan Dann Fesinmeyer; Roman Gulati; Steve Zeliadt; Noel Weiss; Alan R Kristal; Ruth Etzioni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

6.  Is prostatic adenocarcinoma in a relationship with Human Papilloma Virus in Isfahan -Iran.

Authors:  Mojgan Mokhtari; Faegheh Taghizadeh; Mohsen Hani
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.